Thrive Capital Management »

Iovance Biotherapeutics shares owned by Thrive Capital Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Thrive Capital Management from 13F filings

Historical chart of Thrive Capital Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Thrive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Thrive Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $94k 10k 9.39
2024-06-30 $81k 10k 8.02
2024-03-31 $148k 10k 14.82
2023-12-31 $81k 10k 8.13
2023-09-30 $46k 10k 4.55

More positions owned by Thrive Capital Management

Ishares Tr Core Div Grwth (DGRO)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Vanguard Whitehall Fds High Div Yld (VYM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds Value Etf (VTV)
Global X Fds Nasdaq 100 Cover (QYLD)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Ishares Tr Modert Alloc Etf (AOM)

View all positions for Thrive Capital Management

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics